New Treatment Options Available Close to Home

MOUNT KISCO – Northern Westchester Hospital (NWH), a member of Northwell Health, announced that it is the first in Westchester County to offer Aquablationâ therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), or enlarged prostate.

Aquablationâ is a minimally invasive surgical technique performed using the AquaBeamâ Robotic System, the first FDA-cleared surgical robot utilizing automated tissue resection for the treatment of LUTS due to BPH.

BPH is a non-cancerous condition where the prostate has grown to be larger than normal. One in two men between the ages of 51 and 60 have BPH, and the incidence increases every decade of life. If left untreated, BPH can cause significant health problems, including irreversible bladder or kidney damage, bladder stones and incontinence.

“We are proud to be the first in Westchester County to offer a solution for men with BPH that provides significant, long-lasting symptom relief with substantially lower risk to their sexual function or continence,” said Mark Nogueira, MD, specialist in minimally invasive Urologic Oncology, Northern Westchester Hospital. “Aquablationâ therapy is the next step to furthering our commitment to robotic surgery and men’s health. We successfully began the program in January and have a waiting list of those who can benefit from this advanced, non-invasive procedure available here, in their community.”

Aquablationâ therapy combines real-time, multi-dimensional imaging, automated robotics and heat-free waterjet ablation for targeted, controlled and immediate removal of prostate tissue. Combining both cystoscopic (a camera) visualization and ultrasound imaging, surgeons can create a personalized treatment plan tailored to each patient’s anatomy. Once the map is complete, the robotically controlled, waterjet ablates the prostate tissue, avoiding critical structures to preserve sexual function and continence. Proven in numerous clinical studies, Aquablationâ therapy offers predictable and reproducible outcomes, independent of prostate anatomy, or prostate size, which means nearly all men suffering from BPH can receive treatment.

Print Friendly, PDF & Email